TY  - JOUR

T1  - Interleukin-1 beta inhibition with canakinumab and reducing lung cancer—subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)

JO  - Journal of Thoracic Disease

PY  - 2018/09/01

AU  - Crossman D

AU  - Rothman AMK

ED  - 

DO  - DOI: 10.21037/jtd.2018.07.50

PB  - AME Publishing Company

VL  - 10

IS  - S26

SP  - S3084

EP  - S3087

Y2  - 2024/12/22

ER  -